Guru V. Betageri - Search Results

Year	Number of Results
2002	3
2003	2
2005	1
2006	1
2008	1
2009	1
2010	3
2013	3
2014	3
2015	5
2016	3
2018	1
2019	1
2022	1
2024	0

1

Proliposomes for oral delivery: progress and challenges.

Nekkanti V, Venkatesan N, Betageri GV. Nekkanti V, et al. Among authors: betageri gv. Curr Pharm Biotechnol. 2015;16(4):303-12. doi: 10.2174/1389201016666150118134256. Curr Pharm Biotechnol. 2015. PMID: 25601600 Review.

2

Can formulation and drug delivery reduce attrition during drug discovery and development-review of feasibility, benefits and challenges.

Basavaraj S, Betageri GV. Basavaraj S, et al. Among authors: betageri gv. Acta Pharm Sin B. 2014 Feb;4(1):3-17. doi: 10.1016/j.apsb.2013.12.003. Epub 2014 Jan 24. Acta Pharm Sin B. 2014. PMID: 26579359 Free PMC article. Review.

3

Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione-An Approach to Combat Opportunistic Infections.

Kenchappa V, Cao R, Venketaraman V, Betageri GV. Kenchappa V, et al. Among authors: betageri gv. Appl Sci (Basel). 2022 Feb 1;12(3):1468. doi: 10.3390/app12031468. Epub 2022 Jan 29. Appl Sci (Basel). 2022. PMID: 35663347 Free PMC article.

4

Bioavailability enhancement of glucosamine hydrochloride by chitosan.

Qian S, Zhang Q, Wang Y, Lee B, Betageri GV, Chow MS, Huang M, Zuo Z. Qian S, et al. Among authors: betageri gv. Int J Pharm. 2013 Oct 15;455(1-2):365-73. doi: 10.1016/j.ijpharm.2013.06.055. Epub 2013 Jul 3. Int J Pharm. 2013. PMID: 23830943

5

Design, Characterization, and In Vivo Pharmacokinetics of Tacrolimus Proliposomes.

Nekkanti V, Rueda J, Wang Z, Betageri GV. Nekkanti V, et al. Among authors: betageri gv. AAPS PharmSciTech. 2016 Oct;17(5):1019-29. doi: 10.1208/s12249-015-0428-4. Epub 2015 Oct 19. AAPS PharmSciTech. 2016. PMID: 26729532

6

Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.

Arregui JR, Kovvasu SP, Betageri GV. Arregui JR, et al. Among authors: betageri gv. AAPS PharmSciTech. 2018 May;19(4):1802-1809. doi: 10.1208/s12249-018-0989-0. Epub 2018 Apr 3. AAPS PharmSciTech. 2018. PMID: 29616488

7

Liposomes as nanocarriers for anti-HIV therapy.

Chopra S, Venkatesan N, Betageri GV. Chopra S, et al. Among authors: betageri gv. Drug Deliv Transl Res. 2013 Oct;3(5):471-8. doi: 10.1007/s13346-013-0134-2. Drug Deliv Transl Res. 2013. PMID: 25788354

8

Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.

Kovvasu SP, Kunamaneni P, Yeung S, Rueda J, Betageri GV. Kovvasu SP, et al. Among authors: betageri gv. AAPS PharmSciTech. 2019 Jun 18;20(6):226. doi: 10.1208/s12249-019-1437-5. AAPS PharmSciTech. 2019. PMID: 31214813

9

Improved delivery of cromolyn from oral proliposomal beads.

Deshmukh DD, Ravis WR, Betageri GV. Deshmukh DD, et al. Among authors: betageri gv. Int J Pharm. 2008 Jun 24;358(1-2):128-36. doi: 10.1016/j.ijpharm.2008.02.026. Epub 2008 Mar 6. Int J Pharm. 2008. PMID: 18400424

10

Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women.

Bharadwaj S, Naidu TA, Betageri GV, Prasadarao NV, Naidu AS. Bharadwaj S, et al. Among authors: betageri gv. Inflamm Res. 2010 Nov;59(11):971-8. doi: 10.1007/s00011-010-0211-7. Epub 2010 May 15. Inflamm Res. 2010. PMID: 20473630 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year